ACTIVE

GEVA PHARMA

Export PDF

Financial year 2025 · Closed on 31/12/2025

Net result81,6 k €-6,0 %over 1 year

Gross margin229,7 k €-6,0 %over 1 year

Equity190,4 k €-7,0 %over 1 year

Workforce1,8 ETP0,0 %over 1 year

Identity

Source · BCE/KBO

GEVA PHARMA is a Private limited company incorporated in 1985. Its main activity is: Dispensing chemist in specialised stores. Its registered office is in Oudenaarde. It employs on average 1,8 ETP workers (FTE).

Legal situation: Normal situation
BCE/KBO no. / VAT: BE 0427.597.576
Incorporation: 09/08/1985
Legal form: Private limited company
Registered office: Diependale 8
9700 Oudenaarde · FlandreSee on map
Contributed capital: 18 720,00 €
Latest accounts: 31/12/2025
Average workforce: 1,8 ETP

Activities (NACE)

47730Dispensing chemist in specialised stores· main 47730Dispensing chemist in specialised stores 52310Warehousing and support activities for transportation

Joint committees (1)

Signals

ProfitableLow riskGood liquidityPositive cashflowPositive EBITDAHealthy social debts

Financials

Source · NBB, 21 filings

Trend over 20 financial years

	2025		2024		2023		2022		2021
Income statement
Gross margin	229,7 k €	-6.0%	244,4 k €	-18.8%	300,9 k €	+19.9%	250,9 k €	+50.6%	166,7 k €
EBITDA	105,5 k €	-8.3%	115,1 k €	-34.0%	174,3 k €	+41.1%	123,5 k €	+126%	54,7 k €
Operating result	92 k €	-8.7%	100,7 k €	-35.6%	156,4 k €	+47.2%	106,3 k €	+183%	37,6 k €
Net result	81,6 k €	-6.0%	86,8 k €	-33.0%	129,7 k €	+38.7%	93,5 k €	+110%	44,5 k €
Balance sheet
Equity	190,4 k €	-7.0%	204,8 k €	-1.5%	207,9 k €	+12.9%	184,2 k €	-1.3%	186,7 k €
Total assets	655,2 k €	-8.2%	713,9 k €	-1.0%	721 k €	+9.0%	661,5 k €	+11.1%	595,7 k €
Cash	222,4 k €	-0.5%	223,6 k €	+31.3%	170,3 k €	-8.5%	186,2 k €	+63.8%	113,7 k €
Debts	456,8 k €	-8.5%	499,3 k €	-0.4%	501,3 k €	+8.1%	463,7 k €	+17.8%	393,5 k €
Other
Workforce	1,8 ETP	0.0%	1,8 ETP	-10.0%	2,0 ETP	+5.3%	1,9 ETP	-5.0%	2,0 ETP

Valuation

Indicative valuation

As an indication, this company is worth

between 500 k€ and 1 M€

See the valuation

Board of directors

Source · NBB, accounts to 31/12/2025

2 active · 3 ended

Active mandates

Director	Mandates in this company	Period	Other mandatescurrentendedstruck offbankruptcies
Conrad Pharma0536.875.697Represented by Vanessa Pluym	DirectorManager2019 accountsended
Philippe Verzele	DirectorManager2019 accountsended

Ended mandates

Director	Mandates in this company	Period	Other mandatescurrentendedstruck offbankruptcies
Joseph GEERARDYN	Manager09/08/1985 → 22/02/2010
Rita Theresia VANDEGINSTE	Manager09/08/1985 → 2011 accounts
Rita VANDEGINSTE	Manager09/08/1985 → 2010 accounts

Other companies at this address

Diependale 8 9700 Oudenaarde

Company	CBE no.
Conrad Pharma● Active	0536.875.697
DECAPHAR● Active	0843.302.261
VERZELE PHARMA● Active	0896.764.703
VERZELE PHARMA ZWALM● Active	0475.231.407

Full financial information

Source · NBB

	2025	2024	2023	2022	2021	2020
Type of account	Abridged model	Abridged model	Abridged model	Abridged model	Abridged model	Abridged model
Start of the financial year	01/01/2025	01/01/2024	01/01/2023	01/01/2022	01/01/2021	01/01/2020
Closing of the financial year	31/12/2025	31/12/2024	31/12/2023	31/12/2022	31/12/2021	31/12/2020
Length of the financial year	12 months	12 months	12 months	12 months	12 months	12 months
Filing date	28/08/2026	28/08/2025	12/07/2024	05/07/2023	24/08/2022	14/09/2021
General meeting	24/08/2026	27/08/2025	22/06/2024	24/06/2023	16/08/2022	14/08/2021
Currency of the financial year	EUR	EUR	EUR	EUR	EUR	EUR
NBB quality label	Satisfying controls	Satisfying controls	Satisfying controls	Satisfying controls	Satisfying controls	Satisfying controls

Financial ratios

Source · NBB

Looking for more information about this company?

Try for free

Annual accounts filings

Source · NBB, 21 filings

Model	Closing	General meeting	Filed	Language	Document
Abridged model	31/12/2025	24/08/2026	28/08/2026	Dutch	PDF
Abridged model	31/12/2024	27/08/2025	28/08/2025	Dutch	PDF
Abridged model	31/12/2023	22/06/2024	12/07/2024	Dutch	PDF
Abridged model	31/12/2022	24/06/2023	05/07/2023	Dutch	PDF
Abridged model	31/12/2021	16/08/2022	24/08/2022	Dutch	PDF
Abridged model	31/12/2020	14/08/2021	14/09/2021	Dutch	PDF
Abridged model	31/12/2019	27/08/2020	14/09/2020	Dutch	PDF
Abridged model	31/12/2018	11/09/2019	23/09/2019	Dutch	PDF
Abridged model	31/12/2017	23/06/2018	31/08/2018	Dutch	PDF
Abridged model	31/12/2016	24/06/2017	11/07/2017	Dutch	PDF
Abridged model	31/12/2015	25/06/2016	30/06/2016	Dutch	PDF
Abridged model	31/12/2014	27/06/2015	29/06/2015	Dutch	PDF
Abridged model	31/12/2013	20/09/2014	31/10/2014	Dutch	PDF
Abridged model	31/12/2012	22/06/2013	26/08/2013	Dutch	PDF
Abridged model	31/12/2011	23/06/2012	29/08/2012	Dutch	PDF
Abridged model	31/12/2010	23/04/2011	30/08/2011	Dutch	PDF
Abridged model	31/12/2009	24/04/2010	19/08/2010	Dutch	PDF
Abridged modelCorrection	31/12/2008	20/06/2009	21/08/2009	Dutch	PDF
Abridged model	31/12/2008	20/06/2009	23/07/2009	Dutch	PDF
Abridged model	31/12/2007	21/06/2008	28/08/2008	Dutch	PDF
Abridged model	31/12/2006	30/06/2007	24/07/2007	Dutch	PDF

Indicative valuation

Order of magnitude

As an indication, this company is worth

between 500 k€ and 1 M€

The detail comes with the Business plan: low and high bounds, the valuation bridge for each financial year, transaction multiples by sector and size, group valuation and exports.

Discover the Business plan

Disclaimer

Indicative estimate based on public sector multiples and the filed annual accounts. It is neither a certified valuation nor financial or investment advice.

Board of directors

Source · NBB, accounts to 31/12/2025

2 active · 3 ended

Active mandates

Director	Mandates in this company	Period	Other mandatescurrentendedstruck offbankruptcies
Conrad Pharma0536.875.697Represented by Vanessa Pluym	DirectorManager2019 accountsended
Philippe Verzele	DirectorManager2019 accountsended

Ended mandates

Director	Mandates in this company	Period	Other mandatescurrentendedstruck offbankruptcies
Joseph GEERARDYN	Manager09/08/1985 → 22/02/2010
Rita Theresia VANDEGINSTE	Manager09/08/1985 → 2011 accounts
Rita VANDEGINSTE	Manager09/08/1985 → 2010 accounts

Ownership and network

Looking for more information about this company?

Try for free

Belgian Official Gazette publications

Source · Belgian Official Gazette

Mandates24/01/2024
STATUTEN (VERTALING, COÖRDINATIE, OVERIGE WIJZIGINGEN, ) - WIJZIGING RECHTSVORM - DOEL - ONTSLAGEN - BENOEMINGEN
PDF
Mandates11/10/2017
NAAM - ZETEL - KAPITAALVERMINDERING - ONTSLAG ZAAKVOERDER _ !:
PDF
Capital / shares28/02/2014
BVBA: kapitaalswijziging Ë
PDF
Mandates12/10/2011
ONTSLAGEN - BENOEMINGEN - BOEKJAAR - STATUTEN (VERTALING, COÖRDINATIE, OVERIGE WIJZIGINGEN, )
PDF
Mandates01/12/2010
ONTSLAGEN - BENOEMINGEN
PDF

Similar companies

A company's peers, by sector and size, are included in the Business plan.

See the Business plan

Timeline

Source · CBE, NBB annual accounts

Year

Identity

Incorporation

Name

Registered office

Annual accounts

Filings20 filings

Mandates

Conrad Pharma

Philippe Verzele

Joseph GEERARDYN

Rita Theresia VANDEGINSTE

Rita VANDEGINSTE

198519861987198819891990199119921993199419951996199719981999200020012002200320042005200620072008200920102011201220132014201520162017201820192020202120222023202420252026

GEVA PHARMA

Diependale 8, 9700 Oudenaarde

Director

Manager

CurrentPlanned, not yet servedEndedAccounts filedToday

Registered offices

Source · NBB annual accounts, CBE

Registered address	Period	Source
Diependale 8, 9700 OudenaardeCurrent	accounts 2021 → 2025	Accounts 2025 · 2026-00472398

Company names

Source · NBB annual accounts, CBE

Name	Period	Source
GEVA PHARMACurrent	accounts 2021 → 2025	Accounts 2025 · 2026-00472398

Events

2025
Annual accounts 202581,6 k €↓
2024
Annual accounts 202486,8 k €↓
2023
Annual accounts 2023129,7 k €↑
2022
Annual accounts 202293,5 k €↑
2021
Annual accounts 202144,5 k €↓
2020
Annual accounts 202051,2 k €↑
2019
Annual accounts 201942,2 k €↓
2018
Annual accounts 201862,4 k €↓
2017
Annual accounts 201771,2 k €↑
2016
Annual accounts 201616,3 k €↓
2015
Annual accounts 201525,2 k €↓
2014
Annual accounts 201432,2 k €↓
2013
Annual accounts 201344,9 k €↑
2012
Annual accounts 201234,3 k €↑
2011
Annual accounts 201114,9 k €↑
2010
Annual accounts 20109,7 k €↓
2009
Annual accounts 200918,3 k €↑
2008
Annual accounts 200810,2 k €↓
2007
Annual accounts 200712,7 k €↓
2006
Annual accounts 200615,7 k €
09/08/1985
IncorporationPrivate limited company

GEVA PHARMA

Overview

Identity

Financials

Valuation

Indicative valuation

Board of directors

Other companies at this address

Financials

Full financial information

Financial ratios

Annual accounts filings

Valuation

Indicative valuation

Directors & structure

Board of directors

Ownership and network

Publications

Belgian Official Gazette publications

Similar companies

Similar companies

Timeline

Timeline

Registered offices

Company names

Events